ArticleRheumatology and therapy2022

Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications.

Joseph F Merola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.